Boston Scientific TheraSphere™ Y-90 Glass Microspheres
TheraSphere™ Y-90 Glass Microspheres Late Breaking Data
EPOCH trial represents the first positive phase 3 study for selective internal radiation therapy.
EPOCH trial represents the first positive phase 3 study for selective internal radiation therapy.
Copyright 2025 | All Rights Reserved | Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.